The impact of female obesity on in vitro fertilization outcomes

Slides:



Advertisements
Similar presentations
How Old is Too Old? Age, Genetics and Reproduction
Advertisements

In Vitro Fertilization
New Developments in Assisted Reproduction
Luteal Phase Support in ART Cycles
Ovarian Ageing and Fertility
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Elonva in poor responders
Think about… 4.1 Hormonal control of the menstrual cycle 4.2 Use of hormones Recall ‘Think about…’ Summary concept map.
Puberty and associated changes
Breast Cancer, Fertility and Pregnancy
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
INFERTILITY ASSOCIATED WITH PCOS Dr. Norlia Bahauddin Hospital Kajang.
IVM is ready as a treatment for PCOS patients
PHYSICIAN FLIP CHART. Ottawa Fertility Centre The Egg Donation Process.
Ovaries and the Fertility Cycle
Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles? Peter Platteau, Johan Smitz, Carola Albano, Per Sørensen Joan-Carles Arce.
Safety and efficacy of FSH drugs in ART for polycystic ovarian disease M. Aboulghar Cairo, Egypt.
THE IMPACT OF FEMALE OBESITY ON IN VITRO FERTILIZATION OUTCOMES Prof. Dr. İdris KOÇAK ONDOKUZ MAYIS UNIVERSITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,
Infertility Grand Challenge Seminar Fall, What is infertility? Infertility is the term health care providers use for women of normal childbearing.
ART Assisted reproductive technology Dithawut Khrutmuang MD.
Bilgin GURATES, MD. IMPLANTATION IS OR IS NOT AFFECTED BY ENDOMETRIOSIS It’s a common disease and an enigmatic disease This database gives us the dimension.
الجامعة السورية الخاصة كلية الطب البشري قسم طب المجتمع
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Hormonal Control in Males Hypothalamus GnRH FSH Anterior pituitary Sertoli cells Leydig cells Inhibin Spermatogenesis Testosterone Testis LH Negative feedback.
CONCEPTION, DEVELOPMENT, AND BIRTH CHAPTER 46 (AP BOOK)
Chapter 15 Reproductive System.
Embryo development Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
The Effect of Bromocriptine-Rebound Method on Ongoing Pregnancy and Live Birth after Intracytoplasmic Sperm Injection Cycles: a Randomized Clinical Trial.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
Human Reproduction 6.6.
TEMPLATE DESIGN © IMPACT OF SEXUAL ABSTINENCE DURATION ON ICSI OUTCOME May Kew Loke and Pak Seng Wong Sunfert International.
Agonist vs Antagonist Dr. Milton Leong.
Aline de Cássia Azevedo (a,b) ; Fernanda Coimbra Miyasato (b) ; Litsuko S. Fujihara (b), Maria Cecília R.M. Albuquerque (b), Ticiana V. Oliveira (b), Luiz.
Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes Debbra A. Keegan, M.D., Lewis C. Krey, Ph.D., Hung-Chi Chang, M.D.,
Methods of assisted reproduction MUDr.Jitka Řezáčová ÚPMD, Praha 4, Podolí.
The Challenge of the Miracle of Life - Infertility Jennifer McDonald DO.
A review on the luteal phase P Devroey MD PhD Centre for Reproductive Medicine Dutch-speaking Brussels Free University Brussels - Belgium.
Luteal coasting post GnRH agonist trigger
Methods Interleukim6,Interleukin 1 ,Estradiol and Testosterone Concentrations in Serum and Follicular Fluid of females with stimulated and non-stimulated.
Organismal Development Part 4
Physiology and health Unit 2. 1 Reproduction (a) (i)The structure and function of reproductive organs and gametes and their role in fertilisation. Gamete.
(Miz Medi Hospital) Jung-Hyun Cho, M.D. (Miz Medi Hospital) Minimal Ovarian Stimulation.
Rifat GÜRSOY, M.D. GAZİ UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF GYNECOLOGY AND OBSTETRICS REPRODCTIVE ENDOCRINOLOGY AND INFERTILITY DIVISION GÜVEN.
PROFESSOR ZEINAB ABOTALIB Consultant Obstetrics & Gynaecology and infertility.
6.6 Hormones, homeostasis and reproduction Understanding: -Insulin and glucagon are secreted by alpha and beta cells in the pancreas to control blood glucose.
Konstantin Y. Boyarsky1,2, MD, PhD
Fertility Facts Definition:unprotected sex for one year, not pregnant
Role of decreased androgens in the ovarian response to stimulation in older women Fertil Steril Jan;99(1):5-11 Presented by Hsing-Chun Tsai
INTRAUTERINE DEVICES- A HIGHLY EFFECTIVE METHOD OF CONTRACEPTION By Megan Klein.
An analysis of 2,566 cycles Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: An analysis of 2,566.
Jeannie Harper, PhD, RN Southeastern Louisiana University.
Male Reproductive Anatomy (Front View). Male Reproductive Anatomy (Side View)
Welcome.
Endometrial biopsy in subfertile women undergoing intrauterine insemination (IUI) cycles improves pregnancy rates Tumanyan A, Tchzmachyan R, Grigoryan.
Freeze All The Paradigm Shift
ultrasound of the female pelvis
Isfahan University of Medical Sciences Dissertation defense meeting Resident of Gynecology and Obstetrics.
Mohamed Elmahdy MD. Lecturer Obs. Gyn. Alexandria University Egypt
Obesity and its metabolic complications in IVF
Reproduction-Related Disorders
Oocyte Donation; Factors Influencing The Outcome
Organismal Development Part 4
6.6 Hormones, homeostasis and reproduction
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
Organismal Development Part 4
Presentation transcript:

The impact of female obesity on in vitro fertilization outcomes Evangelos Makrakis MD, PhD Director of EMBRYO A.R.T. Unit Athens, Greece

obesity: epidemiology obesity is the new worldwide epidemic in USA and Europe 60% of all women are overweight (BMI>25 kg/m2) 30% of them are obese (BMI>30 kg/m2) 6% of them are morbidly obese (BMI>40 kg/m2) 50% of women 25-44 years old are overweight 20% of them are obese definition of obesity Body Mass Index (BMI): 18.5 – 25 – 30 – 35 – 40 kg/m2 waist circumference to define truncal/abdominal obesity OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and infertility obese women: x3 times at risk of infertility in the presence of irregular cycles associated with oligo-anovulation in the presence of regular cycles probability of pregnancy is reduced by 5% for every BMI unit that exceeds 29 kg/m2 anovulation even with regular cycles release of oocytes with reduced fertilization potential endometrial abnormalities underlying mechanisms insulin resistance hyperandrogenism elevated leptin levels and leptin resistance OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and assisted reproductive technologies (A.R.T.) obesity can be main, secondary or accompanying infertility factor high prevalence of OW or OB women who need A.R.T. the impact of obesity on A.R.T. outcomes is debatable British Fertility Society guidelines infertility treatment should be deferred until BMI<35 kg/m2 or even until BMI<30 kg/m2 in young women with good ovarian reserve OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and IVF outcomes problems with the studies retrospective: nearly all heterogeneity: clinical, methodological, statistical different cut-off values for BMI analysis of overweight and obese women as one group different stimulation protocols different starting doses of gonadotropins different metabolic and endocrine patterns in each woman unable to adjust for confounders age PCOS poor response type of obesity (truncal) OBESITY AND IVF - 2010 E. MAKRAKIS

in vitro fertilization (IVF) controlled ovarian stimulation oocyte retrieval in vitro fertilization embryo culture embryo-transfer support of luteal phase OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation total dose of gonadotropins: higher in OW and OB WMD: weighted mean difference Maheshwari et al, 2007 : 37 papers for effects of obesity on ART- 12 papers actually included OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation number of retrieved oocytes: fewer in OW and OB WMD: weighted mean difference Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation cancellation rates: higher in OW and OB OR: odds ratio Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation OHSS: higher in OW and OB OR: odds ratio Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation Bellver et al, 2009: the largest single center study (6500 IVF cycles) total dose of gonadotropins: higher in OW and OB number of retrieved oocytes: similar in NW/OW/OB peak E2 levels: similar in NW/OW/OB studies with opposite conclusions [number of studies] same response to gonadotropins in NW/OW/OB [4] lower dose of gonadotropins in OB [5] fewer days of stimulation in OB [3] similar peak E2 levels [8] OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation conflicting results may be due to confounders PCOS Martinuzzi et al(2008): similar need for FSH but PCOS patients started with lower dose Dokras et al(2006): in BMI>40, PCOS patients had fewer cancellations and stimulation days compared to non-PCOS age Sneed at al (2008): high BMI has a more profound negative effect in number of retrieved oocytes in younger patients Martinuzzi et al (2008): included only young patients and found no effect of BMI on ovarian response OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation ‘gonadotropin resistance’ exogenous FSH threshold increases with BMI greater amount of body surface differences in absorption and metabolic clearance altered peripheral steroid metabolism and decreased SHBG levels impaired absorption due to increased subcutaneous fat (not likely) OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and ovarian stimulation ‘gonadotropin resistance’ independent role of insulin and IGF-1 NW-IR-PCOS women are still gonadotropin resistant role of leptin: high levels – resistance in OB high intra-follicular levels: associated with gonadotropin resistance inhibitory effect on developing follicles inhibits FSH and LH stimulated steroidogenesis in granulosa cells OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and oocyte retrieval number of retrieved oocytes in OW/OB women metanalysis of Maheshwari et al(2007): significantly decreased number decreased number: 9 studies similar number: 9 studies mechanisms fewer growing follicles technically difficult retrievals there are no studies confirming more difficult retrievals OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates BMI >25 vs <25: lower pregnancy rates Maheshwari et al, 2007 : 37 papers for effects of obesity on ART- 12 papers actually included OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates BMI >30 vs <30: lower pregnancy rates Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates BMI >25 vs 20-25: lower pregnancy rates Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates BMI >30 vs 20-30: lower pregnancy rates Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates Maheshwari et al, 2007 OW and OB women face a reduced likelihood of pregnancy theory of inverted U: low BMI has similar detrimental effect on pregnancy rates Metwally et al, 2007 no effect of BMI on clinical pregnancy rates Martinuzzi et al, 2008 trend to lower implantation and ongoing pregnancy rates in PCOS patients with high BMI Sneed et al, 2008 analysis of the interaction BMIxAGE effect on pregnancy rates in younger ages (<35 years) BMI has a significant negative impact on implantation, pregnancy, and livebirth rates it may be reasonable to delay treatment in younger women and recommend weight loss OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and pregnancy rates in obese: lower implantation, pregnancy, livebirth rates in overweight: lower implantation, pregnancy, livebirth rates raising BMI by 1 unit: odds for pregnancy decrease by 0.98 reducing BMI by 1 unit: odds for pregnancy increase by 1.19 Bellver et al, 2009 OBESITY AND IVF - 2010 E. MAKRAKIS

mechanisms for reduced pregnancy rates difficult embryotransfers (ET)? ET under ultrasound guidance improves pregnancy rates proven [Cochrane Review, 2007] the quality of visualization correlates with pregnancy rates if excellent/good: 41.5% - if fair/poor: 16.7% [Wood et al,2000] in obese: difficulty to see the air-bubble of the catheter and tendency for blood in the catheter tip [Martinuzzi et al, 2008] impaired oocyte-embryo quality? impaired endometrial receptivity? placement of embryos tip of external catheter sheath OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and oocyte quality Cano et al, 1997 PCOS women with recurrent failures who were also donors Group I: no own pregnancy, no recipient pregnancy Group II: no own pregnancy, no recipient pregnancy Group III: non-PCOS controls doing IVF impaired oocyte quality and increased BMI in group I Whittemer et al, 2000 fewer metaphase II (MII) oocytes in BMI≥25 vs. BMI 20-25 Carrel et al, 2001 fewer metaphase II (MII) oocytes in BMI≥30 vs. BMI 20-30 Dokras et al, 2006 fewer mature oocytes by nuclear assessment in BMI≥40 Balaban et al, 2006 negative impact of increased BMI Esinler et al, 2008 negative impact of increased BMI Metwally et al, 2007 no effect of increased BMI Bellver et al, 2009 no effect of increased BMI OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and fertilization rates Salha et al, 2001 reduced FR in BMI >26(26.6%) vs. BMI 18-25(37.1%) van Swieten et al, 2006 reduced (by 45%) FR in BMI≥30 Matalliotakis et al, 2008 reduced FR in BMI >24(51.7%) vs. BMI <24(58.9%) Lashen et al, 1999 no effect of increased BMI Whittemer et al, 2000 no effect of increased BMI Fedorcsak et al, 2004 no effect of increased BMI Dokras et al, 2006 no effect of increased BMI Esinler et al, 2006 no effect of increased BMI Dechaud et al, 2006 no effect of increased BMI Metwally et al, 2007 no effect of increased BMI Martinuzzi et al, 2008 no effect of increased BMI Bellver et al, 2009 no effect of increased BMI OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and embryo quality Spandorf et al, 2004 impaired embryo quality in BMI >30 Dechaud et al, 2006 impaired embryo quality in BMI >30 Metwally et al, 2007 impaired embryo quality, fewer cryopreserved embryos, more discarded embryos in obese women younger than 35 years Carrell et al, 2001 no effect of increased BMI Fedorcsak et al, 2004 no effect of increased BMI Arce et al, 2006 no effect of increased BMI Bendus et al, 2006 no effect of increased BMI Esinler et al, 2008 no effect of increased BMI Bellver et al, 2009 no effect of increased BMI OBESITY AND IVF - 2010 E. MAKRAKIS

mechanisms for impaired oocyte/embryo quality high doses of gonadotropins due to ‘resistance’ impair embryo quality abnormal embryonic development reduced invasional capacity of blastocyst induce defects in embryos and oocytes induce chromosomal defects in oocytes inverse correlation between BMI and intra-follicular HCG concentrations low concentrations affect embryo quality becomes significant in obese women OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and endometrium oocyte donation models use of oocytes from young donors with normal weight transfer to recipient and analysis according to their BMI effects on pregnancy rates (if any) should be attributed to endometrial factors Wattanakumtornkul et al, 2003 no effect of increased BMI on pregnancy rates BUT very small sample (7 lean, 12 obese, 97 cycles) Bellver et al, 2003 trend towards reduced implantation and pregnancy rates x4 increase in miscarriages BUT small sample and not only the 1st cycles included Styne-Gross et al, 2005 no effect of increased BMI on pregnancy rates BUT very high miscarriage rate for unknown reasons OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and endometrium Bellver et al, 2007 2656 first oocyte donation cycles lower implantation and pregnancy rates as BMI increases higher miscarriage rate as BMI increases lower ongoing pregnancy rate in OW and OB ongoing PR in BMI<25: 45.5% in BMI>25: 38.3% OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and endometrium Bellver et al, 2007 2656 first oocyte donation cycles excess weight may exert an extra-ovarian detrimental effect the effect on the endometrium seems subtle but should be taken into account being overweight implies negative impact as being obese underweight women do not experience poorer outcomes in donation models the theory of inverted U is applied only to native oocyte conceptions, based on the ovarian effect of underweight OBESITY AND IVF - 2010 E. MAKRAKIS

mechanisms for impaired endometrium hyper-estrogenic state due to high activity of aromatase system: increased E production decreased SHBG: increased free E2 delivered to target tissues increased estrone – decreased inactive metabolites results in extremely thick endometrium: if>14mm is associated with lower PR (controversial) more endometrial polyps and more multiple polyps defective endometrium due to inverse correlation between BMI and E and PG receptors in endometrium LIF in endometrial glands leukocyte subpopulations OBESITY AND IVF - 2010 E. MAKRAKIS

mechanisms for impaired endometrium other effects leptin resistance in peripheral tissues insulin resistance and hyperinsulinemia reduced glycodelin in endometrium: associated with recurrent pregnancy loss reduced IGF-binding protein (facilitates adhesion at maternal-fetal surface) increased acute phase proteins & pro-inflammatory cytokines (IL6, PAI-1, TNFa) negative effect on endometrium and early embryonic development OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and miscarriages BMI >25 vs <25: higher miscarriage rates Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and miscarriages BMI >30 vs <30: higher miscarriage rates Maheshwari et al, 2007 OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and miscarriages BMI >25 vs <25: higher miscarriage rates Metwally et al, 2008: 25 studies(1964-2006) – 16 studies included – 16696 patients OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and miscarriages Odds ratio of miscarriage after ovulation induction: BMI>25 vs. <25: higher miscarriage rates Odds ratio of miscarriage after IVF/ICSI: BMI>25 vs. <25: higher miscarriage rates OR 1.52, 95%CI 0.88-2.61 Metwally et al, 2008 BUT problem with inclusion criteria (old age, PCOS) and publication bias (negative studies) OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and miscarriages Veleva et al, 2008 U-shaped effect of BMI on miscarriage rates after IVF (p=0.01) in fresh cycles: 13.4% in natural thaw cycles 11.4% in hormonal thaw cycles: 23% (risk x 1.7, p= 0.002) Bellver et al, 2009 no effect of BMI on miscarriage rates perhaps because no differences to embryo quality were noted OBESITY AND IVF - 2010 E. MAKRAKIS

mechanisms for increased miscarriages hormonal alterations endometrial receptivity trophoblast function early embryo development insulin resistance impaired progesterone release: inhibits normal corpus luteum function reduced IGF binding protein reduced aνb3 integrin reduced adhesion molecules reduced glycodelin in endometrium leptin when high or resistance: leads to insulin resistance state when low: detrimental to early embryo development and trophoblast invasion OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and IVF: most recent studies Kupka et al, 2010 retrospective analysis of 706360 cycles from German registry dataset inclusion of female and male weights the combination of obese male and normal-weight female is positively related to increased implantation rates after IVF/ICSI this combination is more likely in couples with higher social status: the result may be related to lifestyle factors Keltz et al, 2010 retrospective analysis of 290 cycles male overweight status was associated with significantly lower clinical pregnancy rate after IVF (53.2% vs 33.6%), but not after ICSI ICSI may overcome some obesity-related impairement of sperm-egg interaction OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and IVF: most recent studies Zhang et al, 2010 retrospective analysis of 2628 cycles in Chinese couples obese women higher FSH dose – more stimulation days – fewer oocytes – lower fertilization rates overweight women fewer oocytes – lower fertilization rates – fewer cleavaged, high-grade and cryopreserved embryos no differences in pregnancy/miscarriage/live birth rates Vilarino et al, 2010 retrospective analysis of 208 cycles no differences in FSH dose-number of oocytes-fertilization rate-embryo quality- frozen embryos clinical pregnancy/miscarriage/live birth rates OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and IVF: conclusions even though no evidence-based consensus obesity may have negative effects on ovarian stimulation parameters oocyte and embryo quality fertilization rates embryo transfer implantation rates pregnancy rates miscarriage rates OBESITY AND IVF - 2010 E. MAKRAKIS

obesity and IVF: conclusions fewer growing follicles fewer retrieved oocytes difficult retrievals reduced implantation and pregnancy rates poor quality of oocytes low fertilization rates poor quality of embryos poor outcome increased miscarriage rates impaired embryotransfer due to technical problems impairment of endometrium and its receptivity OBESITY AND IVF - 2010 E. MAKRAKIS

thank you Evangelos Makrakis MD, PhD Director of EMBRYO A.R.T. Unit Athens, Greece